THCV
Psychoactive
C₁₉H₂₆O₂

THCV

Tetrahydrocannabivarin

The "diet weed" — a unique cannabinoid that suppresses appetite, regulates blood sugar, and may hold the key to cannabis-based diabetes treatment.

THCV is a structural analog of THC with a propyl rather than pentyl side chain. At low doses it acts as a CB1 antagonist — suppressing appetite and reducing THC's psychoactive effects. At high doses it becomes a CB1 agonist with its own psychoactive properties. Its metabolic effects have attracted significant pharmaceutical interest for obesity and type 2 diabetes.

Boiling Point
220°C (428°F)
Onset (Sublingual)
Oral: 30–90 min
Duration
Inhaled: 1–2 hours (shorter than THC)
Natural Source
<1% in most cannabis; up to 5% in specialized strains

What is THCV?

Tetrahydrocannabivarin (THCV) is one of the most pharmacologically interesting minor cannabinoids, with a unique dose-dependent mechanism that sets it apart from all other cannabinoids. At low doses, THCV acts as a CB1 receptor antagonist — blocking the receptor and suppressing appetite, reducing THC's psychoactive effects, and improving insulin sensitivity. At higher doses (above approximately 10mg), it switches to a CB1 agonist, producing its own psychoactive effects described as clear-headed and energetic.

The appetite-suppressing properties of THCV have earned it the nickname "diet weed" and attracted significant pharmaceutical interest. GW Pharmaceuticals (now Jazz Pharmaceuticals) conducted Phase 2 clinical trials of THCV for type 2 diabetes, finding significant improvements in fasting plasma glucose, adiponectin levels, and HDL cholesterol compared to placebo.

THCV is found in highest concentrations in African sativa landrace strains — particularly those from South Africa, Nigeria, and Ethiopia. Modern breeding programs have developed high-THCV strains including Durban Poison, Doug's Varin, and Pineapple Purps. Commercial THCV products are typically produced from these strains or through biosynthesis.

Beyond metabolic effects, THCV has demonstrated anticonvulsant properties in animal models, neuroprotective effects in Parkinson's disease models (reducing tremors and improving motor control), and bone-stimulating properties that may be relevant for osteoporosis treatment.

THCV's unique biphasic pharmacology makes dosing critical. Low-dose THCV (2–5mg) is used for appetite suppression and metabolic benefits without psychoactivity. Higher doses produce a fast-onset, clear-headed, energetic high that dissipates more quickly than THC. This rapid onset and offset has been described as a "cleaner" high by experienced users.

Legal Gray Area

THCV's legal status is complex. Hemp-derived THCV (from plants with ≤0.3% total THC) may be legal under the Farm Bill, but THCV itself is structurally similar to THC and may be considered a controlled substance analog. State laws vary significantly.

Key Facts

  • Structural analog of THC with propyl side chain
  • CB1 antagonist at low doses — appetite suppression
  • CB1 agonist at high doses — psychoactive
  • GW Pharmaceuticals conducted Phase 2 diabetes trials
  • Highest concentrations in African sativa landraces
  • Shorter duration than THC — faster onset and offset
  • Neuroprotective in Parkinson's disease models

Important Warnings

  • Legal status uncertain — check state and federal laws
  • Dose-dependent psychoactivity — start very low
  • Limited human clinical trial data
  • May interact with diabetes medications (blood sugar effects)
  • Drug testing: may cross-react with THC tests
Pharmacology
FormulaC₁₉H₂₆O₂
Boiling Point220°C (428°F)
Half-LifeNot well established; likely similar to THC
OnsetInhaled: 2–5 min | Oral: 30–90 min
DurationInhaled: 1–2 hours (shorter than THC) | Oral: 3–5 hours
SourceAfrican sativa landrace strains; Durban Poison, Doug's Varin; trace amounts in most cannabis
Concentration<1% in most cannabis; up to 5% in specialized strains

Legal Status

Legal Gray Area

THCV's legal status is complex. Hemp-derived THCV (from plants with ≤0.3% total THC) may be legal under the Farm Bill, but THCV itself is structurally similar to THC and may be considered a controlled substance analog. State laws vary significantly.

Staff-Tested THCV Products

Our editorial team has tested hundreds of THCV-containing products. These brands consistently deliver the highest quality formulations, most transparent lab testing, and best therapeutic outcomes.

CBDDR.com
Editor's Choice
Broad Spectrum CBD (THC Non-Detect)
98
/ 100
Best Broad Spectrum CBD & Best THC-Free Topical 2020–2026

Same world-leading scientist as CBDWellness. Verified THC non-detect on every batch by ISO 17025 accredited lab — trusted by military, athletes, and law enforcement.

The only broad spectrum brand staff trust for drug-tested professionals.

Best For

Drug-Tested Athletes
Military & Law Enforcement
Anxiety
Chronic Pain
Zero THC Required
ISO 17025 Third-Party Tested · Batch-Level COA Published · Staff Tested

Editorial Disclosure: These brands are selected by our editorial team based on independent staff testing, lab result analysis, and 7 years of annual awards data. We do not accept payment for editorial placement. See our Annual Awards methodology for full details.